Celularity (CELU) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free CELU Stock Alerts $3.05 +0.06 (+2.01%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCelularity Inc. (NASDAQ:CELU) Short Interest Updatemarketbeat.com - April 30 at 2:02 PMCelularity Inc. to Host Investor and Analyst Research & Development Dayglobenewswire.com - April 22 at 8:00 AMCelularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filingglobenewswire.com - April 19 at 5:30 PMCelularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024globenewswire.com - April 18 at 4:30 PMCelularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Productsglobenewswire.com - April 15 at 8:00 AMCelularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cellsglobenewswire.com - April 8 at 9:00 AMCelularity Inc. (NASDAQ:CELU) Short Interest Down 16.8% in Marchmarketbeat.com - March 30 at 3:18 PMCelularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3Lfinance.yahoo.com - March 26 at 9:07 AMCelularity Inc.: Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophyfinanznachrichten.de - March 20 at 10:49 PMCelularity Announces Submission Of Request For Orphan Drug Designation For PDA-002markets.businessinsider.com - March 20 at 10:49 PMCelularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophyglobenewswire.com - March 20 at 9:15 AMCELU Apr 2024 10.000 callfinance.yahoo.com - March 16 at 2:14 AMCELU Mar 2024 7.500 putfinance.yahoo.com - March 15 at 11:13 AMCelularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summitfinance.yahoo.com - March 14 at 9:48 AMCelularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summitglobenewswire.com - March 14 at 9:15 AMCelularity Inc. (NASDAQ:CELU) Short Interest Down 87.6% in Februarymarketbeat.com - March 12 at 12:12 PMCelularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congressglobenewswire.com - March 12 at 9:20 AMCelularity Inc. Class Aedition.cnn.com - March 8 at 7:15 AMCelularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cellsglobenewswire.com - March 7 at 9:35 AMmarketbeat.com - February 29 at 6:00 AMCelularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Splitfinanznachrichten.de - February 24 at 9:51 AMStocks to Watch: Intuitive Machines, Celularitymarketwatch.com - February 23 at 11:10 PMCelularity Announce 1-for-10 Reverse Stock Splitmarkets.businessinsider.com - February 23 at 6:10 PMCelularity to Effect 1-for-10 Reverse Stock Splitmarketwatch.com - February 23 at 6:10 PMCelularity Announces 1-for-10 Reverse Stock Splitglobenewswire.com - February 23 at 4:10 PMCelularity Inc.'s (NASDAQ:CELU) top owners are public companies with 35% stake, while 35% is held by individual investorsfinance.yahoo.com - February 22 at 7:06 AMCelularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Diseasefinance.yahoo.com - February 14 at 8:16 PMCelularity's Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Diseaseglobenewswire.com - February 14 at 4:05 PMCelularity Stock (NASDAQ:CELU) Dividends: History, Yield and Datesbenzinga.com - February 6 at 9:35 AMCelularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipelinefinance.yahoo.com - February 1 at 9:33 AMCelularity and Genting Leaders Comments on Closing $21 Million Financing Transactionsfinance.yahoo.com - January 25 at 1:44 PMCelularity, Inc.: Celularity Releases CEO Letter to Shareholdersfinanznachrichten.de - January 19 at 9:05 AMCelularity CEO Says 2023 Revenue to Rise About 23% to 27%marketwatch.com - January 18 at 2:06 PMCelularity Releases CEO Letter to Shareholdersfinance.yahoo.com - January 18 at 2:06 PMCelularity Gets Commercialization Deal For Oral Healthcare Productsmarketwatch.com - January 4 at 4:01 PMCelularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcarefinance.yahoo.com - January 4 at 4:01 PMCelularity, Inc.: Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023finanznachrichten.de - January 3 at 2:01 PMCelularity Expects 4Q Product, Services Sales to Nearly Triplemarketwatch.com - January 3 at 2:01 PMCelularity announces fourth-quarter full-year 2023 revenue outlookmsn.com - January 3 at 2:01 PMCelularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023finance.yahoo.com - January 3 at 2:01 PMCelularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filingfinance.yahoo.com - December 2 at 8:50 AMCelularity, Inc.: Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filingfinanznachrichten.de - November 27 at 10:36 AMCelularity announces receipt of Nasdaq notice regarding late Form 10-Q filingmsn.com - November 24 at 2:31 PMNorth American Morning Briefing: Stock Futures Muted; Nvidia Slips in Offhours Tradingmorningstar.com - November 22 at 9:58 AMCelularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classificationfinance.yahoo.com - October 18 at 10:56 AMCelularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classificationfinance.yahoo.com - October 18 at 10:56 AMCelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directorsfinance.yahoo.com - September 7 at 4:55 PMCelularity Inc - Ordinary Shares - Class Amoney.usnews.com - September 1 at 12:59 PMCelularity, Inc.: Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneronfinanznachrichten.de - August 29 at 6:18 PMCelularity Announces Multi-Year Research Collaboration Services Agreement With Regeneronfinance.yahoo.com - August 29 at 6:18 PM Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. CELU Media Mentions By Week CELU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELU News Sentiment▼1.870.43▲Average Medical News Sentiment CELU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELU Articles This Week▼11▲CELU Articles Average Week Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RPHM News Today ANVS News Today IMMX News Today CALC News Today AEON News Today ELDN News Today CKPT News Today KZR News Today EGRX News Today BLRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELU) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
